Viewing Study NCT00277758



Ignite Creation Date: 2024-05-05 @ 4:36 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00277758
Status: TERMINATED
Last Update Posted: 2008-03-07
First Post: 2006-01-12

Brief Title: Safety Study of Low Dose Interleukin 2 IL-2 Plus PEG-IFNRBV In Chronic Hepatitis C Virus Genotype I
Sponsor: Weill Medical College of Cornell University
Organization: Weill Medical College of Cornell University

Study Overview

Official Title: A Phase I Study of Low Dose Interleukin 2 IL-2Monotherapy Followed by IL-2 Plus PEG-IFNRBV In Chronic Hepatitis C Virus Genotype I Infection
Status: TERMINATED
Status Verified Date: 2008-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Insufficient rate of volunteer accrual
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a treatment study trial in which we will assess the safety and tolerability of daily dose IL-2 as monotherapy for 12 weeks followed by IL2 in combination with PEG-IFN and RBV for 48 weeks in the treatment of chronic Hepatitis C
Detailed Description: This is a single center study of 12 weeks of IL-2 lead in immunotherapy followed by 48 weeks of IL2 immunotherapy in combination with Pegylated Interferon Alpha PEG-IFN-alpha Ribavirin RBV antiviral therapy for the treatment of individuals infected with Hepatitis C virus HCV genotype I The study is designed to determine whether immunotherapy immunotherapy with low dose daily IL-2 can be safely added to the standard antiviral therapy of 48 weeks of PEG-IFN and RBV Because IL-2 targets recently antigen- activated T cells IL-2 therapy will be initiated 12 weeks before PEG-IFNRBV therapy when HCV antigen load is high to activate and expand HCV antigen-specific T cells prior to the initiation of antiviral therapy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
U01AI048224 NIH None httpsreporternihgovquickSearchU01AI048224